BioCina (AAA- rated as in Access, Ability, Agility) is a biologics contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacture of microbial-based therapeutics and plasmid DNA, from preclinical to commercial production. The site, approved by the FDA for commercial manufacturing in 2020, has 35+ years of microbial fermentation experience and over the past 15 years, has worked on over 50 different products and has partnered with more than 40 customers globally. With customized services, BioCina has successfully performed multiple technology transfers, and developed unique solutions to address technical issues for customers’ programs. BioCina strives to provide high quality, cost effective microbial process development and manufacturing solutions to customers worldwide.